Abiopharma

🔍 MACDONALD LAURA ANN (Executive)

Company: COGNEX CORP (CGNX)

Report Date: 2025-09-05

Detailed Transactions and Holdings:

• Sold 2,666 shares of Common Stock at $45.0 per share (Direct)
  Date: 2025-09-05 | Code: S | equity_swap_involved: 0 | shares_owned_after: 4,593.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2025-09-05 | Code: H | nature_of_ownership: By Child | shares_owned_after: 20.00 | Footnotes: F2
• Holds 33,168 shares of Non-Qualified Stock Option (right to buy) at $33.04 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2035-02-18 | Exercise: 2026-02-18 | shares_owned_after: 33,168.00
• Holds 12,500 shares of Non-Qualified Stock Option (right to buy) at $38.39 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2027-02-21 | Exercise: 2018-02-21 | shares_owned_after: 12,500.00
• Holds 37,698 shares of Non-Qualified Stock Option (right to buy) at $39.44 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2034-02-20 | Exercise: 2025-02-20 | shares_owned_after: 37,698.00
• Holds 30,492 shares of Non-Qualified Stock Option (right to buy) at $47.21 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2033-02-21 | Exercise: 2024-02-21 | shares_owned_after: 30,492.00
• Holds 10,000 shares of Non-Qualified Stock Option (right to buy) at $48.28 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2029-05-01 | Exercise: 2022-05-01 | shares_owned_after: 10,000.00
• Holds 42,500 shares of Non-Qualified Stock Option (right to buy) at $50.94 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2030-02-18 | Exercise: 2021-02-18 | shares_owned_after: 42,500.00
• Holds 30,000 shares of Non-Qualified Stock Option (right to buy) at $51.49 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2029-02-19 | Exercise: 2020-02-19 | shares_owned_after: 30,000.00
• Holds 15,000 shares of Non-Qualified Stock Option (right to buy) at $56.44 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2028-02-20 | Exercise: 2019-02-20 | shares_owned_after: 15,000.00
• Holds 23,891 shares of Non-Qualified Stock Option (right to buy) at $64.43 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2032-02-22 | Exercise: 2023-02-22 | shares_owned_after: 23,891.00
• Holds 13,946 shares of Non-Qualified Stock Option (right to buy) at $90.5 per share (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2031-02-16 | Exercise: 2022-02-16 | shares_owned_after: 13,946.00
• Holds 2,754 shares of Restricted Stock Unit (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2026-02-21 | Exercise: 2024-02-21 | shares_owned_after: 2,754.00
• Holds 5,071 shares of Restricted Stock Unit (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2027-02-20 | Exercise: 2025-02-20 | shares_owned_after: 5,071.00
• Holds 982 shares of Restricted Stock Unit (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2027-03-15 | Exercise: 2025-03-15 | shares_owned_after: 982.00
• Holds 12,107 shares of Restricted Stock Unit (Derivative)
  Date: 2025-09-05 | Code: H | Expires: 2028-02-18 | Exercise: 2026-02-18 | shares_owned_after: 12,107.00

Footnotes:

• F1: These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
• F2: Held by reporting person's child. The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.